BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16397079)

  • 1. Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model.
    Wu G; Yu L; Wang L; Wang H; Xuan JW
    Postgrad Med J; 2006 Jan; 82(963):40-5. PubMed ID: 16397079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological characteristics of a novel knock-in mouse prostate cancer model.
    Wu G; Wang D; Wang H; Yuan J; Xuan JW
    Braz J Med Biol Res; 2006 Jun; 39(6):759-65. PubMed ID: 16751981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies.
    Gabril MY; Duan W; Wu G; Moussa M; Izawa JI; Panchal CJ; Sakai H; Xuan JW
    Mol Ther; 2005 Mar; 11(3):348-62. PubMed ID: 15727931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model.
    Duan W; Gabril MY; Moussa M; Chan FL; Sakai H; Fong G; Xuan JW
    Oncogene; 2005 Feb; 24(9):1510-24. PubMed ID: 15674347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.
    Moussa M; Kloth D; Peers G; Cherian MG; Frei JV; Chin JL
    Clin Invest Med; 1997 Dec; 20(6):371-80. PubMed ID: 9413634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
    Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; RuĂ  S
    Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between nuclear DNA and histologic grade of prostatic carcinoma].
    Zattoni F; Prayer Galetti T; Vianello F; Bertoldin R; Panozzo M; Blandamura S; Costantin G
    J Urol (Paris); 1992; 98(4):192-5. PubMed ID: 1284300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
    Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
    Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological significance and predictive value for biochemical recurrence of c-Fes expression in prostate cancer.
    Miyata Y; Watanabe S; Matsuo T; Hayashi T; Sakai H; Xuan JW; Greer PA; Kanda S
    Prostate; 2012 Feb; 72(2):201-8. PubMed ID: 21563194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
    Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
    J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level.
    McGuire BB; Helfand BT; Loeb S; Hu Q; O'Brien D; Cooper P; Yang X; Catalona WJ
    BJU Int; 2012 Jun; 109(12):1764-9. PubMed ID: 22017732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA cytometric proliferative index predicting organ confinement in clinical stage-B prostate cancer.
    Moussa M; Song TY; Frei JV; Peers G; Chin JL
    Clin Invest Med; 1997 Apr; 20(2):119-26. PubMed ID: 9088668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end point.
    Delahunt B; Lamb DS; Srigley JR; Murray JD; Wilcox C; Samaratunga H; Atkinson C; Spry NA; Joseph D; Denham JW
    Pathology; 2010 Jun; 42(4):339-43. PubMed ID: 20438406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
    Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
    Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
    Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours.
    Corcoran NM; Hovens CM; Hong MK; Pedersen J; Casey RG; Connolly S; Peters J; Harewood L; Gleave ME; Goldenberg SL; Costello AJ
    BJU Int; 2012 Mar; 109(5):660-4. PubMed ID: 21895937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.